The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia (Q89701501)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

title

The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

Publisher Correction: The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia

7 April 2020

corrigendum / erratum

0 references

author

Andreas H. Kottmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Julia Castello

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Marisol Cortés

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Lauren Malave

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

David R Sibley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Eitan Friedman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Heike Rebholz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

publication date

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

page(s)

2542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

How common are the "common" neurologic disorders?

7 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

1 reference

7 January 2021

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Muscarinic IPSPs in rat striatal cholinergic interneurones

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Dopamine D5 receptors of rat and human brain

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

D5 Dopamine Receptors Enhance Zn2+-Sensitive GABAA Currents in Striatal Cholinergic Interneurons through a PKA/PP1 Cascade

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Behavioral characterization of dopamine D5 receptor null mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Methamphetamine increases locomotion and dopamine transporter activity in dopamine d5 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Differentiation of forebrain and hippocampal dopamine 1-class receptors, D1R and D5R, in spatial learning and memory

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

The Dopamine D5 Receptor Is Involved in Working Memory

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Enhanced striatal cholinergic neuronal activity mediatesl-DOPA–induced dyskinesia in parkinsonian mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Striatal cholinergic interneurons display activity-related phosphorylation of ribosomal protein S6

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Activation of D1/5 Dopamine Receptors: A Common Mechanism for Enhancing Extinction of Fear and Reward-Seeking Behaviors

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

D5 dopamine receptors are required for dopaminergic activation of phospholipase C.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

l-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

The striatal cholinergic system in L-dopa-induced dyskinesias.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Cholinergic control of firing pattern and neurotransmission in rat neostriatal projection neurons: role of CaV2.1 and CaV2.2 Ca2+ channels

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Muscarinic modulation of striatal function and circuitry.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-59011-5

7 January 2021

Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/32054879

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41598-020-59011-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32054879%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

PubMed publication ID

32054879

1 reference